Kalamazoo, MI, United States of America

Michael R Barbachyn


Average Co-Inventor Count = 3.3

ph-index = 17

Forward Citations = 700(Granted Patents)


Location History:

  • Kalamazoo, MI (US) (1990 - 2010)
  • Ann Arbor, MI (US) (2006 - 2013)

Company Filing History:


Years Active: 1990-2013

Loading Chart...
40 patents (USPTO):

Title: Michael R. Barbachyn: Innovator in Antibacterial Compounds

Introduction

Michael R. Barbachyn, based in Kalamazoo, MI, is a prominent inventor known for his significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial agents. With a remarkable portfolio of 40 patents, Barbachyn has played a pivotal role in advancing medicinal chemistry.

Latest Patents

Among his latest innovations are two noteworthy patents. The first, titled "Tricyclic Tetrahydroquinoline Antibacterial Agents," focuses on tricyclic tetrahydroquinoline compounds and their pharmaceutically acceptable salts. These compounds exhibit useful antibacterial activity against a broad spectrum of human and veterinary pathogens. The second patent, "N-aryl-2-oxazolidinone-5-carboxamides and Their Derivatives," describes new antibacterial agents that are detailed through various formulae.

Career Highlights

Michael has a rich career marked by his work at notable organizations, including Pharmacia & Upjohn Company and The Upjohn Company. His expertise in medicinal chemistry has led to significant advancements in the development of effective antibacterial treatments.

Collaborations

Throughout his career, Barbachyn has collaborated with esteemed colleagues such as Steven J. Brickner and Richard Charles Thomas. These partnerships have further enriched the innovation landscape within the pharmaceutical sector, contributing to the success of their collective endeavors.

Conclusion

With a strong focus on antibacterial innovations, Michael R. Barbachyn continues to make impactful contributions to the medical field. His patents play a crucial role in addressing the challenges posed by infectious diseases, highlighting his dedication to improving global health through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…